NASDAQ •
Healthcare •
Biotechnology •
Quote as of 09/14/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4.02 mln
Float1.14 mln
Earnings Date11/13/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
6
/ 100
Severely lagging
Pre-Tax Margin
-14,152%
Severely loss-making
ROE
-1,889
Deeply negative
Altman Z-Score
-22.2
Deeply distressed
ROA
-233
Deeply negative
Business Description
Jupiter Neurosciences is a pharmaceutical company based in Jupiter, Florida, focused on developing treatments for brain and nervous system diseases using a compound called resveratrol. The company currently has five drug candidates in Phase II clinical trials, targeting conditions such as Friedreich's Ataxia, early Alzheimer's disease, Parkinson's disease, and two other rare neurological disorders. Beyond prescription treatments, Jupiter Neurosciences also works with partners to create consumer health products aimed at healthy aging and longevity.
